
Tushar Gore
Dr Tushar Gore is the managing director of Resonance Laboratories, a niche pharmaceutical manufacturer. Dr Gore studied at IIT-Bombay and the University of Minnesota, and has worked at McKinsey and Novo Nordisk. His focus area is pharmaceuticals
Authors you can follow
More From Tushar Gore

An economic power requires mindsets and skills to appreciate and enhance good qualitySubscriber Only
July 15,2024 18:40:19 PM
India has pockets of excellence in which people are committed to good quality. The challenge is to make this achievement broad-based
Wed, Aug 14, 2024
Do high levels of ‘good’ cholesterol mean lower risk of heart disease? How HDL-C is actually linked to cardiovascular healthSubscriber Only
February 14,2024 20:01:48 PM
When looking at diagnostic test results, it is important to understand the difference between correlation and causation, to decide on the appropriate intervention. Here, we explain the link between HDL-Cholesterol and heart health.
Fri, Feb 16, 2024
Testing to prevent heart attack in asymptomatic people: Required, wasteful or dangerous?Subscriber Only
June 12,2023 17:09:32 PM
These tests are not 100 per cent accurate and a positive result does not always mean the individual has the disease. And vice versa. Such tests in asymptomatic individuals are generally not recommended and might even be dangerous, says Tushar Gore
Wed, Jun 21, 2023
How to minimise risks of a surprise heart attack and young deathsSubscriber Only
August 03,2022 15:03:51 PM
Sudden attacks are caused by smaller blockages. These are “clinically silent” and do not restrict blood flow but cause problems if they break apart. This initiates blood clotting mechanisms to “repair” the injury from the plaque disruption that often result in blockage, says Tushar Gore.
Wed, Sep 21, 2022
An Expert Explains: Why vaccine efficacy is declining, and the implications of a third doseSubscriber Only
September 27,2021 04:02:58 AM
Recent data suggest that the effectiveness of Covid-19 vaccines has been declining. A look at the possible reasons, and the implications of a third dose.
Tue, Sep 28, 2021
Why 30x undercount in Covid deaths is unlikelySubscriber Only
July 24,2021 04:00:10 AM
Tushar Gore and Viral V Acharya write: High death undercounts are limited to short time spans when the capacity is overwhelmed. For eight districts that have been analysed, it is roughly between 3-9x.
Tue, Jul 27, 2021
An Expert Explains: AstraZeneca vaccine and the Covid-19 variants in IndiaSubscriber Only
May 24,2021 01:04:06 AM
New data from the UK demonstrate the effectiveness of AstraZeneca’s vaccine against the B.1.617.2 variant first detected in India. How should we interpret the findings, and can they impact India’s vaccination policy?
Thu, Aug 04, 2022
An Expert Explains: The complexities of herd immunitySubscriber Only
April 27,2021 04:15:24 AM
In several metros where serosurveys showed high immunity levels, Covid cases are still surging. What does that say about the concept of 'herd immunity'? Accounting for transmission involves several factors.
Fri, Apr 30, 2021
Explained: A year on, making sense of India’s Covid-19 dataSubscriber Only
April 02,2021 04:20:53 AM
Coronavirus in India: It is not yet clear why the numbers declined for five months and then rose again. An analysis of data leads to more confounding questions, and some contradictory findings; we have to rely on many conjectures.
Thu, Aug 04, 2022
An Expert Explains: Four key things you must know about Covid-19 vaccinesSubscriber Only
September 11,2020 20:20:49 PM
What are the issues of safety and efficacy that you hear about? When will a vaccine be available? Is the vaccine being fast-tracked, and, therefore, unsafe? Can we trust the vaccine when it is approved?
Wed, Sep 16, 2020
An Expert Explains: Should you test for Covid-19 just to check?Subscriber Only
August 01,2020 04:00:53 AM
Not advised, because the probability of being falsely identified as Covid-19-positive is quite high. When no test is 100% accurate, the key aspect to consider is disease prevalence in the population that is being tested
Mon, Aug 03, 2020a better experience